Company Filing History:
Years Active: 2023
Title: Jacek Krol: Innovator in Retinal Research
Introduction
Jacek Krol is a notable inventor based in Basel, Switzerland. He has made significant contributions to the field of biomedical research, particularly in the area of retinal pigment epithelium cell-specific gene expression. With a total of 2 patents, his work has the potential to impact therapeutic approaches for retinal diseases.
Latest Patents
Jacek Krol's latest patents include a method for expressing an exogenous gene specifically in cells of the retinal pigment epithelium of primates. This method involves delivering an isolated nucleic acid molecule that leads to the expression of an exogenous gene when linked to the appropriate nucleic acid sequence. Another significant patent is SynPIII, which provides an isolated nucleic acid molecule that specifically promotes gene expression in retinal pigment epithelium cells.
Career Highlights
Throughout his career, Jacek Krol has worked with esteemed organizations such as the Friedrich Miescher Institute for Biomedical Research and the Novartis Research Foundation. His research has focused on advancing our understanding of gene expression in retinal cells, which is crucial for developing new treatments for vision-related disorders.
Collaborations
Jacek has collaborated with notable colleagues, including Josephine Juettner and Botond Roska. These partnerships have fostered a collaborative environment that enhances the research output and innovation in the field.
Conclusion
Jacek Krol's contributions to retinal research through his patents and collaborations highlight his role as an innovator in the biomedical field. His work continues to pave the way for advancements in gene therapy for retinal diseases.